# Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection

> **NCT04344600** · PHASE2 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 6 (actual)

## Conditions studied

- Sars-CoV-2 Infection

## Interventions

- **DRUG:** Peginterferon lambda alfa-1a subcutaneous injection
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT04344600
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-29
- **Primary completion:** 2021-09-24
- **Final completion:** 2021-09-24
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Single center study with low enrollment
- **Last updated:** 2022-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04344600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04344600, "Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04344600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*